Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740902011 | Isoniazid and rifampin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740903018 | Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740904012 | Isoniazid and rifampicin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5567301000241119 | produit contenant seulement de l'isoniazide et de la rifampicine sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Is a | Product containing isoniazid and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Has active ingredient | Isoniazid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 1 | |
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Is a | Isoniazid and rifampicin only product | true | Inferred relationship | Some | ||
| Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Isoniazid 150 mg and rifampicin 300 mg oral capsule | Is a | True | Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR